|
Market Closed -
Nasdaq
21:00:00 10/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.860 USD | -0.27% |
|
+1.09% | -46.24% |
| 08-24 | Grace Therapeutics Files for Resale of Up to 4.8 Million Shares | MT |
| 08-13 | Grace Therapeutics, Inc. Reports Impairment charges for the First Quarter Ended June 30, 2026 | CI |
Stock exchange
Quotes 5-day view: Grace Therapeutics, Inc.
Delayed Quote Nasdaq
| 04/11/2026 | 05/11/2026 | 06/11/2026 | 09/11/2026 | 10/11/2026 | |
|---|---|---|---|---|---|
| Last | US$1.810 | US$1.780 | US$1.850 | US$1.865 | US$1.860 |
| Volume | 64,541 | 97,130 | 114,883 | 128,723 | 27,964 |
| Change | -1.63% | -1.66% | +3.93% | +0.81% | -0.27% |
| Opening | US$1.849 | US$1.810 | US$1.850 | US$1.900 | US$1.840 |
| High | US$1.960 | US$1.900 | US$1.900 | US$1.940 | US$1.920 |
| Low | US$1.780 | US$1.750 | US$1.790 | US$1.860 | US$1.840 |
Performance
| 1 day | -0.27% | ||
| 1 week | +1.09% | ||
| Current month | -4.12% | ||
| 1 month | -10.58% | ||
| 3 months | -11.85% | ||
| 6 months | -20.51% | ||
| Current year | -46.24% | ||
| 1 year | -37.79% | ||
| 3 years | -16.36% | ||
| 5 years | -81.44% | ||
| 10 years | -97.01% |
Volumes
marketsDaily volume
27,964
Estimated daily volume
27,964
Avg. Volume 20 sessions
131,784
Daily volume ratio
0.21
Avg. Volume 20 sessions USD
245,118.24
Record volume 1
11,730,010
Record volume 2
7,917,576
Record volume 3
6,546,727
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
39,126,829
Net sales (CAD)
0
Net sales (USD)
0
Number of employees
5
Sales / Employee (CAD)
0
Sales / Employee (USD)
0
Free-Float
81.32%
Free-Float capitalization (USD)
31,819,834
Average Daily Capital Traded
0.44%
Indicators
Moving average 5 days
1.833
Moving average 20 days
1.896
Moving average 50 days
2.033
Moving average 100 days
2.146
Price spread / (MMA5)
-1.45%
Price spread / (MMA20)
+1.94%
Price spread / (MMA50)
+9.32%
Price spread / (MMA100)
+15.38%
STIM
RSI 9 days
46.65
RSI 14 days
44.88
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.09% | -37.79% | -16.36% | 39.13M | |
| +0.01% | +11.10% | +60.83% | +70.43% | 68.32B | |
| +0.81% | +6.90% | +14.24% | +89.35% | 60.26B | |
| +0.09% | +0.03% | +19.72% | +97.20% | 55.86B | |
| +1.60% | +19.44% | +28.80% | +112.95% | 48.43B | |
| -1.32% | +4.78% | +29.15% | +40.40% | 45.34B | |
| -3.54% | -0.60% | +207.76% | +879.50% | 41.76B | |
| -3.33% | +6.90% | +22.78% | +48.07% | 34.5B | |
| -1.26% | -1.20% | +84.21% | +56.55% | 33.8B | |
| -1.49% | +1.16% | +47.05% | +0.16% | 25.96B | |
| Average | -0.87% | +4.96% | +47.68% | +137.83% | 41B | |
| Weighted average by Cap. | -0.66% | +5.25% | +53.97% | +152.62% |
Historical Quotes: Grace Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
7d2a8274698.Ko5uRgCDSMgp0cqN5vgqaoagprwivXEtVmNe_un8SCo.RcReA2qwHItZufPi3o5IX7Lpy_IT5xNAHARmuIqJDVtg4SkfTPB7smi5qQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 21:00:00 | 1.860 | 1,453 | 23,393 |
| 20:59:31 | 1.845 | 100 | 21,940 |
| 20:59:31 | 1.845 | 100 | 21,840 |
| 20:59:26 | 1.845 | 100 | 21,740 |
| 20:59:26 | 1.870 | 100 | 21,640 |
| 20:59:26 | 1.870 | 100 | 21,540 |
| 20:59:24 | 1.870 | 100 | 21,440 |
| 20:59:24 | 1.860 | 100 | 21,340 |
| 20:58:05 | 1.850 | 300 | 21,240 |
| 20:58:05 | 1.850 | 100 | 20,940 |
Price Extremes
| 1 week | 1.75 |  | 1.94 |
| 1 month | 1.67 | | 2.07 |
| Current year | 1.67 | | 5.18 |
| 1 year | 1.67 | | 5.18 |
| 3 years | 1.67 | | 5.18 |
| 5 years | 1.67 | | 10.74 |
| 10 years | 1.67 | | 161.11 |
Monthly variations
Annual variations
| 2026 | -46.24% | ||
| 2025 | -7.49% | ||
| 2024 | +29.41% | ||
| 2023 | -3.86% | ||
| 2022 | -60.24% | ||
| 2021 | -51.54% | ||
| 2020 | -86.73% | ||
| 2019 | +194.51% | ||
| 2018 | -11.76% | ||
| 2017 | -24.58% | ||
| 2016 | -50.98% | ||
| 2015 | -49.00% | ||
| 2014 | -60.00% | ||
| 2013 | -41.91% | ||
| 2012 | +62.29% | ||
| 2011 | +8.08% |
- Stock Market
- Stocks
- GRCE Stock
- Quotes Grace Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
